Use this banner section for site-wide announcements, news updates, big changes and more.
About
LVEF
Deidentification
News
Contact Us
InVision obtains FDA 510k Clearance for Breakthrough Device, InVision Precision Cardiac Amyloid
May 28, 2025
Business
InVision enters artificial intelligence collaboration with Alexion to explore potential to improve detection of cardiac amyloidosis
InVision receives U.S. FDA Clearance for Precision LVEF
InVision Announces Adoption of New CPT Billing Code for InVision Precision Cardiac Amyloid by the American Medical Association
InVision receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm
Product
Our approach to onboarding team members
Write a brief description of the article here.
Business
Measuring customer satisfaction.
Write a brief description of the article here.
Product
Perfecting the packaging experience.
Write a brief description of the article here.
Business
Facilitating actionable feedback.
Write a brief description of the article here.
Customers achieve great results when they switch to Adept.
Arrange a demo
Search
Enter keywords and click search.
Quick links
Tour
Product Tour 1
Customers
Pricing 1
How It Works